Compare LIC MF Healthcare Fund vs ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund
Risk
Very High
Very High
Rating
1.0
5.0
Min SIP Amount
₹200
₹100
Expense Ratio
2.44
2.19
NAV
₹33.88
₹44.45
Fund Started
08 Feb 2019
25 Jun 2018
Fund Size
₹84.53 Cr
₹6668.95 Cr
Exit Load
Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.
Exit load of 1% if redeemed within 15 days.
1 Year
8.09%
5.68%
3 Year
21.98%
26.25%
5 Year
10.54%
15.27%
Equity
96.12%
96.76%
Cash
3.88%
3.24%
Top 10 Holdings
Sun Pharmaceutical Industries Ltd. | 11.22% |
Apollo Hospitals Enterprise Ltd. | 6.52% |
Torrent Pharmaceuticals Ltd. | 6.50% |
Aurobindo Pharma Ltd. | 5.15% |
Divi's Laboratories Ltd. | 4.74% |
Fortis Healthcare Ltd. | 4.70% |
Neuland Laboratories Ltd. | 4.59% |
Onesource Specialty Pharma Ltd. | 4.56% |
Piramal Pharma Ltd. | 4.33% |
Glenmark Pharmaceuticals Ltd. | 3.41% |
Sun Pharmaceutical Industries Ltd. | 11.76% |
Cipla Ltd. | 8.15% |
Mankind Pharma Ltd. | 7.58% |
Divi's Laboratories Ltd. | 6.06% |
Dr. Reddy's Laboratories Ltd. | 5.94% |
Biocon Ltd. | 5.81% |
Cohance Lifesciences Ltd. | 4.44% |
Lupin Ltd. | 3.80% |
Medplus Health Services Ltd. | 3.37% |
Alkem Laboratories Ltd. | 3.24% |
Name
-
-
Start Date
-
-
Description
The Scheme seeks to achieve long term capital appreciation by predominantly investing in equity and equity related instruments of companies engaged in Healthcare and Allied sectors.
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
Launch Date
08 Feb 2019
25 Jun 2018
